The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects
Clinical trial NCT03663686 · COMPLETED
Trial details
- NCT number
- NCT03663686
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2019-01-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.